<DOC>
	<DOCNO>NCT02292290</DOCNO>
	<brief_summary>Dual therapy metformin Liraglutide effective help people establish Type 2 Diabetes Mellitus ( T2DM ) observe Ramadan achieve triple composite endpoint weight reduction and/or maintenance improve HaemaglobinA1c ( HbA1c ) severe hypoglycaemic event .</brief_summary>
	<brief_title>Trial People With Established Type 2 Diabetes During Ramadan</brief_title>
	<detailed_description>Participants control arm essentially continue standard routine care intervention group either receive Liraglutide addition metformin dual therapy switch sulphonylurea/pioglitazone Liraglutide continue metformin . Informed consent baseline data collect 4-8 week prior start Ramadan . This allow time run period titration Liraglutide prior fast period . Ramadan follow Eid-al-Fitr 3-day Islamic holiday mark end holy month . Tradition include amongst early morning prayers/celebration feasting . Therefore , participant invite attend first follow-up event ( week 2 - 4 ) 12 week post Ramadan . Randomisation reveal baseline data collect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Individuals â‰¥ 18 year old establish T2DM metformin dual therapy metformin plus sulphonylurea pioglitazone HbA1c 7 11 % monotherapy 6.5 12 % dual therapy Are pregnant breast feeding Suffer terminal illness Have significant renal liver impairment Are unable provide inform consent Have severe endure mental health problem Are primarily responsible care Are receive insulin therapy Type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>Ramadan</keyword>
	<keyword>fast</keyword>
</DOC>